Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062296
Status:
COMPLETED
Last Update Posted:
2013-07-11
First Post:
2003-06-05
Brief Title:
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma or Chronic Lymphocytic Leukemia
Sponsor:
Fox Chase Cancer Center
Organization:
Fox Chase Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| B-cell chronic lymphocytic leukemia | View |
| refractory chronic lymphocytic leukemia | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |